Christopher Chapman

Dr Christopher Chapman is a Lecturer in Bioengineering at Queen Mary University of London's School of Engineering and Materials Science. He serves as the Biomedical Engineering Programme Director (Undergraduate) and Outreach and Recruitment Lead for The Centre for Bioengineering. With expertise in bioelectronics design and fabrication for central and peripheral nervous system targets, Chapman leads research focused on developing soft and flexible bioelectronic implants using both metals and conducting polymers.

• Lecturer in Bioengineering
• Biomedical Engineering Programme Director (Undergraduate)
• Outreach and Recruitment Lead, Centre for Bioengineering
• Member, Institute of Materials, Minerals, and Mining
• Member, Institute of Physics and Engineering in Medicine

Chapman's research interests center around bioelectronics, implanted devices, cancer neuroscience, conductive polymers, and electrical stimulation and recording. His work combines functional materials with laser-based fabrication methods to develop bioelectronic implants for cancer therapeutics and monitoring. He specializes in creating soft, flexible bioelectronic systems that can provide both therapeutic effects and diagnostic feedback from the tumor microenvironment.

Analysis of Chapman's recent publications reveals a strong focus on developing novel bioelectronic materials and devices, particularly using conductive polymers and elastomers. His research spans neural interfaces, cancer monitoring, and drug delivery systems, with increasing emphasis on cancer neuroscience applications in recent years. The publications demonstrate a progression from fundamental materials development to more clinically relevant applications, especially in tumor margin detection and cancer microenvironment monitoring.

Chapman currently leads the Continuous Advanced Recording for Cancer Lab (CARC Lab), which focuses on four key research areas: materials development, in vitro models of cancer, clinical measurements, and therapeutic drug delivery. His research group includes PhD students Joshua Daoud and Ester Do Couto Lopes, who are working on multimodal bioelectronic sensor development for real-time monitoring of the brain tumor microenvironment.

Chapman has secured significant research funding for his work, including a £403,666 grant from the ARIA Advanced Research and Invention Agency for 'Oligodendronics: Engineering biology for scalable neural interfaces', a £74,990 grant from Barts and the London Charity for 'Development of multimodal tumour margin detection paradigm for use in neurosurgical oncology', and a £20,000 grant from the Royal Society for 'Customizable conducting elastomers for bioelectronics sensors'.